OOIR: Observatory of International Research

Papers

(The H4-Index of International Journal of Pharmaceutics is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Editorial Board	139
Levilactobacillus brevis surface layer protein B promotes liposome targeting to antigen-presenting cells in Peyer’s patches	139
Effects of particle size and release property of paclitaxel-loaded nanoparticles on their peritoneal retention and therapeutic efficacy against mouse malignant ascites	138
Editorial Board	123
Practical use of primary drying models in an industrial environment with limited availability of equipment sensors	115
In vivo methodologies to assist preclinical development of topical fixed-dose combinations for pain management	113
Corrigendum to article “Clotrimazole nanoemulsion for malaria chemotherapy. Part II: Stability assessment, in vivo pharmacodynamic evaluations and toxicological studies” [Int. J. Pharm. 431(1–2) (2012	111
Corrigendum to “Mechanistic modeling of twin screw wet granulation for pharmaceutical formulations: Calibration, sensitivity analysis, and model-driven workflow” [Int. J. Pharm. 659 (2024) 124246]	101
Corrigendum to “Investigation on hot melt extrusion and prediction on 3D printability of pharmaceutical grade polymers” [Int. J. Pharm. 604 (2021) 120755]	100
Evaluation of immune-modulating drugs for use in drug-eluting microsphere transarterial embolization	100
Corrigendum to “Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect” [Int. J. Pharm. 652 (2024) 123802]	98
A quantification of gastric and duodenal fluid volumes in older adults using MRI	96
Novel microparticulate Zika vaccine induces a significant immune response in a preclinical murine model after intramuscular administration	96
From laminar to turbulent flow in a dry powder inhaler: The effect of simple design modifications	91
A framework to optimize spring-driven autoinjectors	83
(E, E)-farnesol and myristic acid-loaded lipid nanoparticles overcome colistin resistance in Acinetobacter baumannii	82
Evaluation of a polymeric topical formulation of Endoxifen in an estrogen receptor positive breast cancer murine model	81
Protective role of transforming growth factor-Β3 (TGF-Β3) in the formation of radiation-induced capsular contracture around a breast implant: In vivo experimental study	80
In situ gel-forming oil as rectally delivering platform of hydrophobic therapeutics for ulcerative colitis therapy	78
Tumor-specific targeting of polymer drug delivery systems with recombinant proteins bound via tris(nitrilotriacetic acid)	78
Editorial Board	74
Editorial Board	74
Increased bioavailability of a P-gp substrate: Co-release of etoposide and zosuquidar from amorphous solid dispersions	73
DNA-templated nanosheets for enhanced chemodynamic therapy and gene therapy to inhibit tumor recurrence and metastasis	72
Wharton's jelly mesenchymal stem cell-derived small extracellular vesicles as natural nanoparticles to attenuate cartilage injury via microRNA regulation	71

Synergistic therapy with celastrol-curcumin multifunctional nanomedicine: Anti-hepatocellular carcinoma and reduced hepatotoxicity	70
Tablet diversion strategy based on in-line NIR tablet press feed frame measurements	70
Gypenoside A-loaded mPEG-PLGA nanoparticles ameliorate high-glucose-induced retinal microvasculopathy by inhibiting ferroptosis	70
Characterization and bioavailability of a novel coenzyme Q10 nanoemulsion used as an infant formula supplement	69
Disulfiram 3D printed film produced via hot-melt extrusion techniques as a potential anticervical cancer candidate	67
An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable	66
Simultaneous modeling prediction of three key quality attributes of tablets by powder physical properties	63
Exploiting inhalable microparticles incorporating hybrid polymer-lipid nanoparticles loaded with Iloprost manages lung hyper-inflammation	63
The application of Near-Infrared Spatially Resolved Spectroscopy in scope of achieving continuous real-time quality monitoring and control of tablets with challenging dimensions	63
Polymer-inducing chemical degradation of amorphous solid dispersions driven by drug-polymer interactions for physical stabilization	61
Efficacy and safety of nanoparticles of glibenclamide and organomodified layered double hydroxides in diabetics rats	60
Pharmacokinetic profile, tissue residue depletion and anthelmintic efficacy of supramolecular fenbendazole	59
F3 peptide functionalized liquid crystalline nanoparticles for delivering Salinomycin against breast cancer	59
Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a novel approach for the treatment of pulmonary arterial hypertension	57
Fused deposition modeling 3D printing of solid oral dosage forms containing amorphous solid dispersions: How to elucidate drug dissolution mechanisms through surface spectral analysis techniques?	57
Paliperidone palmitate as model of heat-sensitive drug for long-acting 3D printing application	57
Ophthalmic wild olive (ACEBUCHE) oil nanoemulsions exert oculoprotective effects against oxidative stress induced by arterial hypertension	57
Enhanced dissolution rate of nimodipine through β-lactoglobulin based formulation	56
Low molecular weight fucoidan modified nanoliposomes for the targeted delivery of the anti-inflammation natural product berberine	55
Particulate levodopa nose-to-brain delivery targets dopamine to the brain with no plasma exposure	55
Lactoferrin decorated bilosomes for the oral delivery of quercetin in type 2 diabetes: In vitro and in vivo appraisal	54
Calreticulin P-domain-derived “Eat-me” peptides for enhancing liposomal uptake in dendritic cells	54
Mast cell activators as adjuvants for intranasal mucosal vaccines	54
Hyaluronic acid-functionalized DDAB/PLGA nanoparticles for improved oral delivery of magnolol in the treatment of ulcerative colitis	54
Quality by design – Spray drying of ciprofloxacin-quercetin fixed-dose combination intended for inhalation	54
Tumor microenvironment stimuli-responsive lipid-drug conjugates for cancer treatment	53
Chitosan-based buccal mucoadhesive patches to enhance the systemic bioavailability of tizanidine	53
Oxygen Sensitive Drug Release Using Hemoglobin Microbubbles: A New Approach to Targeting Hypoxia in Ultrasound-Mediated Drug Delivery	52
Heme oxygenase 1 inhibitor discovery and formulation into nanostructured lipid carriers as potent and selective treatment against triple negative metastatic breast cancer	52
Antibody-siRNA conjugates (ARCs) using multifunctional peptide as a tumor enzyme cleavable linker mediated effective intracellular delivery of siRNA	52
A material-sparing simplified buoyancy method for determining the true density of solids	52
Cochleate drug delivery systems: An approach to their characterization	52